5 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Unknown 5 |
Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas Topamax, Levetiracetam - Chronic Subdural Hematoma, Epilepsy; Seizure | Phase 4 | Unknown | Université de Sherbrooke | 56 | 2021-03-01 | 2021-04-30 |
| SEroma Reduction pOst MAstectomy "SEROMA Study" Tranexamic Acid 100mg/mL, 20mL topical, Normal Saline Flush, 0.9%, 20mL topical - Seroma Complicating A Procedure, Hematoma Postoperative | Phase 4 | Unknown | Hamilton Health Sciences Corporation | 100 | 2019-10-07 | 2021-02-21 |
| Tranexamic Acid for Bleeding in Breast Surgery Tranexamic Acid, Placebo - Hematoma, Seroma | Phase 4 | Unknown | Ottawa Hospital Research Institute | 800 | 2016-02-01 | 2016-01-12 |
| Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas active product ( Thrombexx) assigned to arm 1, Placebo assigned to arm 2 - r-Hirudin (Thrombexx) Efficacy in Treatment of Haematomas | Phase 4 | Unknown | MinaPharm Pharmaceuticals | 200 | 2013-10-01 | 2013-10-10 |
| Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma? discontinuation of aspirin therapy, continuation of aspirin therapy - Head Trauma, Traumatic Brain Injury | Phase 4 | Unknown | Hadassah Medical Organization | 100 | 2012-02-01 | 2012-01-18 |
Hematoma, Subdural, Chronic (2) · Seroma (2) · Brain Injuries, Traumatic (1) · Breast Neoplasms (1) · Craniocerebral Trauma (1) · Epilepsy (1)
Hemorrhage (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Chronic Disease (2) · Disease Attributes (2) · Hematoma, Subdural (2) · Inflammation (2) · Intracranial Hemorrhage, Traumatic (2) · Intracranial Hemorrhages (2) · Nervous System Diseases (2)
Tranexamic Acid (2) · Levetiracetam (1) · Topiramate (1)
Hadassah Medical Organization (1) · Hamilton Health Sciences Corporation (1) · MinaPharm Pharmaceuticals (1) · Ottawa Hospital Research Institute (1) · Université de Sherbrooke (1)
Canada (2) · Egypt (1) · Israel (1)
Ahmed Moneer, Dr (1) · Christian Iorio-Morin, MD (1) · Eyal Itshayek, MD (1) · Mahmoud Hafez, Professor (1) · Nicole Hodgson, MD, MSc, FRCSC (1)